Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Black Diamond Therapeutics Inc (BDTX)
Fair Value2.7% Upside Fair Analyst450.7% Upside Market Cap102 M P/E-2.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Bolt Biotherapeutics (BOLT)
Fair Value41.1% Upside Undervalued Analyst938.0% Upside Market Cap7.59 M P/E-0.3x Yield0.0% HealthFair
  NASDAQ
Briacell Therapeutics Corp (BCTX)
Fair Value27.7% Upside Undervalued Market Cap29.244 M P/E-1.0x Yield0.0% HealthWeak
  NASDAQ
BridgeBio Pharma Inc (BBIO)
Fair Value-3.6% Downside Fair Analyst29.5% Upside Market Cap16.044 B P/E-22.2x Yield0.0% HealthGood
  NASDAQ
Burning Rock Biotech Ltd (BNR)
Fair Value45.6% Upside Undervalued Market Cap94.601 M P/E-10.7x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
C4 Therapeutics Inc (CCCC)
Fair Value5.3% Upside Fair Analyst268.3% Upside Market Cap399.1 M P/E-3.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Cabaletta Bio Inc (CABA)
Fair Value-1.5% Downside Fair Analyst393.5% Upside Market Cap451.7 M P/E-2.5x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Candel Therapeutics Inc (CADL)
Fair Value-32.4% Downside Overvalued Analyst96.0% Upside Market Cap770.1 M P/E-14.1x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
Caribou Biosciences Inc (CRBU)
Fair Value27.9% Upside Undervalued Analyst645.3% Upside Market Cap155.7 M P/E-1.2x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Celularity Inc (CELU)
Fair Value22.5% Upside Undervalued Market Cap20.361 M P/E-0.2x Yield0.0% HealthFair
  NASDAQ
Century Therapeutics Inc (IPSC)
Fair Value0.2% Upside Fair Analyst141.7% Upside Market Cap362.5 M P/E-3.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Chemomab Therapeutics Ltd DRC (CMMB)
Fair Value-7.9% Downside Fair Analyst185.7% Upside Market Cap12.097 M P/E-1.7x Yield0.0% HealthFair
  NASDAQ
Cibus Inc (CBUS)
Fair Value-6.8% Downside Fair Analyst659.9% Upside Market Cap146.6 M P/E-1.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Clene Inc. (CLNN)
Fair Value-4.7% Downside Fair Analyst498.5% Upside Market Cap67.469 M P/E-2.1x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Climb Bio Inc (CLYM)
Fair Value-6.8% Downside Fair Analyst68.4% Upside Market Cap719.2 M P/E-13.5x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Compass Pathways Plc (CMPS)
Fair Value-23.0% Downside Overvalued Analyst74.9% Upside Market Cap1.592 B P/E-8.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Connect Biopharma Holdings Ltd (CNTB)
Fair Value-27.7% Downside Overvalued Analyst226.8% Upside Market Cap130.3 M P/E-2.1x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Cullinan Oncology LLC (CGEM)
Fair Value-17.7% Downside Fair Analyst79.5% Upside Market Cap1.079 B P/E-4.9x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Cyclerion Therapeutics Inc (CYCN)
Fair Value1.4% Upside Fair Analyst125.4% Upside Market Cap14.887 M P/E-2.9x Yield0.0% HealthFair
  NASDAQ
Damora Therapeutics Inc (DMRA)
Fair Value-39.8% Downside Overvalued Analyst44.9% Upside Market Cap1.848 B P/E-8.1x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks Technical Strength Leaders Small-Cap Stocks
Dermata Therapeutics Inc (DRMA)
Fair Value32.4% Upside Undervalued Analyst241.9% Upside Market Cap4.424 M P/E-0.7x Yield0.0% HealthWeak
  NASDAQ
Design Therapeutics Inc (DSGN)
Fair Value-31.9% Downside Overvalued Analyst54.8% Upside Market Cap826.1 M P/E-12.0x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
DiaMedica Therapeutics Inc (DMAC)
Fair Value-16.4% Downside Fair Analyst132.6% Upside Market Cap352.4 M P/E-10.2x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Dianthus Therapeutics Inc (DNTH)
Fair Value-27.2% Downside Overvalued Analyst14.3% Upside Market Cap6.035 B P/E-35.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Disc Medicine Inc (IRON)
Fair Value-8.3% Downside Fair Analyst28.0% Upside Market Cap2.987 B P/E-12.3x Yield0.0% HealthFair
  NASDAQ
Dogwood Therapeutics Inc (DWTX)
Fair Value4.3% Upside Fair Analyst665.0% Upside Market Cap60.197 M P/E-2.2x Yield0.0% HealthFair
  NASDAQ
Dyne Therapeutics Inc (DYN)
Fair Value-17.0% Downside Fair Analyst50.6% Upside Market Cap4.85 B P/E-9.4x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Elicio Therapeutics Inc (ELTX)
Fair Value0.2% Upside Fair Analyst527.0% Upside Market Cap74.108 M P/E-1.9x Yield0.0% HealthWeak
  NASDAQ
Elutia Inc (ELUT)
Fair Value15.3% Upside Fair Analyst473.4% Upside Market Cap38.55 M P/E-1.8x Yield0.0% HealthFair
  NASDAQ
Equillium Inc (EQ)
Fair Value-5.1% Downside Fair Analyst292.5% Upside Market Cap142.9 M P/E-7.2x Yield0.0% HealthFair
  NASDAQ
Erasca Inc (ERAS)
Fair Value-18.7% Downside Overvalued Analyst22.4% Upside Market Cap6.38 B P/E-23.3x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum
Evaxion AS (EVAX)
Fair Value23.2% Upside Undervalued Analyst277.5% Upside Market Cap24.604 M P/E-2.5x Yield0.0% HealthGood
  NASDAQ
Exagen Inc (XGN)
Fair Value-44.0% Downside Overvalued Analyst48.2% Upside Market Cap155.8 M P/E-8.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Exicure Inc (XCUR)
Fair Value29.8% Upside Undervalued Market Cap9.816 M P/E-1.0x Yield0.0% HealthWeak
  NASDAQ
Foghorn Therapeutics Inc (FHTX)
Fair Value9.3% Upside Fair Analyst134.5% Upside Market Cap285.3 M P/E-3.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Gain Therapeutics Inc (GANX)
Fair Value10.2% Upside Fair Analyst300.0% Upside Market Cap75.071 M P/E-3.6x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Gossamer Bio Inc (GOSS)
Fair Value38.5% Upside Undervalued Market Cap88.726 M P/E-0.5x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Greenwich Lifesciences Inc (GLSI)
Fair Value-22.6% Downside Overvalued Analyst296.1% Upside Market Cap210.6 M P/E-9.5x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
GRI Bio Inc (GRI)
Fair Value19.6% Upside Undervalued Market Cap2.816 M P/E-0.2x Yield0.0% HealthFair
  NASDAQ
HCW Biologics Inc (HCWB)
Fair Value24.1% Upside Undervalued Analyst774.6% Upside Market Cap4.297 M P/E-0.2x Yield0.0% HealthFair
  NASDAQ
Humacyte Inc (HUMA)
Fair Value2.7% Upside Fair Analyst181.2% Upside Market Cap192 M P/E-2.1x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
I Mab (NBP)
Fair Value59.0% Upside Bargain Analyst387.8% Upside Market Cap190.8 M P/E-2.1x Yield0.0% HealthFair
  NASDAQ
Ideaya Biosciences Inc (IDYA)
Fair Value-6.5% Downside Fair Analyst47.1% Upside Market Cap3.484 B P/E-19.9x Yield0.0% HealthGood
  NASDAQ
Immatics NV (IMTX)
Fair Value-17.5% Downside Fair Analyst82.9% Upside Market Cap1.282 B P/E-5.4x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Immuneering Corp (IMRX)
Fair Value23.1% Upside Undervalued Analyst329.5% Upside Market Cap284.7 M P/E-5.2x Yield0.0% HealthFair
  NASDAQ
Immunocore Holdings PLC (IMCR)
Fair Value10.9% Upside Fair Analyst91.0% Upside Market Cap1.691 B P/E-61.4x Yield0.0% HealthGood
  NASDAQ Featured in Small-Cap Stocks
Immunome Inc (IMNM)
Fair Value-18.4% Downside Overvalued Analyst40.2% Upside Market Cap2.838 B P/E-12.9x Yield0.0% HealthFair
  NASDAQ
Immunovant Inc (IMVT)
Fair Value-11.7% Downside Fair Analyst19.8% Upside Market Cap8.124 B P/E-16.0x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
In8bio Inc (INAB)
Fair Value36.1% Upside Undervalued Analyst532.0% Upside Market Cap9.454 M P/E-0.5x Yield0.0% HealthFair
  NASDAQ
Inhibikase Therapeutics Inc (IKT)
Fair Value-22.7% Downside Overvalued Analyst149.0% Upside Market Cap476.8 M P/E-9.2x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Explore listed stocks on NASDAQ with company information and fair value data.